QPlus Pediatric Reference Interval

Overview

Evaluation of coagulation results reported by the Qplus Quantra System to determine pediatric reference range intervals.

Full Title of Study: “Evaluation of a Pediatric Reference Interval Using QPLUS System”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: May 2023

Detailed Description

Single center observational study of the pediatric patient population (< 18yrs) with normal coagulation function to determine the reference range interval for the clotting parameters reported by the Quantra QPlus system.

Interventions

  • Device: Diagnostic Test
    • Diagnostic device to monitor coagulation properties of a whole blood sample at the point of care

Clinical Trial Outcome Measures

Primary Measures

  • Reference range interval for measurement of clot time (CT) parameter
    • Time Frame: Baseline, after access placement before any procedures
    • Reference range interval determined in this study will serve as the reference for CT results in this particular population
  • Reference range interval for measurement of clot time (CTH) parameter
    • Time Frame: Baseline, after access placement before any procedures
    • Reference range interval determined in this study will serve as the reference for CTH results in this particular population
  • Reference range interval for measurement of clot stiffness (CS) parameter
    • Time Frame: Baseline, after access placement before any procedures
    • Reference range interval determined in this study will serve as the reference for CS results in this particular population
  • Reference range interval for measurement of Fibrinogen Contribution to clot stiffness (FCS) parameter
    • Time Frame: Baseline, after access placement before any procedures
    • Reference range interval determined in this study will serve as the reference for FCS results in this particular population
  • Reference range interval for measurement of Platelet Contribution to clot stiffness (PCS) parameter
    • Time Frame: Baseline, after access placement before any procedures
    • Reference range interval determined in this study will serve as the reference for PCS results in this particular population

Participating in This Clinical Trial

Inclusion Criteria

  • <18yrs – Scheduled for procedure requiring anesthesia – Access to blood sampling – Consented Exclusion Criteria:

  • >18yrs of age – pre-term babies – patients with know hematological disorders – Difficult to obtain blood sampling – Has received a blood product transfusion within the last 24hrs. – Legal guardian unwilling to consent

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: 17 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • HemoSonics LLC
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Christopher Tirotta, MD, Principal Investigator, Nicklaus Childrens
  • Overall Contact(s)
    • Julie Navarro, MSN, 7577494622, jnavarro@hemosonics.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.